{"mainPropery":{"diseaseId":7337,"diseaseName":"Paroxysmal nocturnal hemoglobinuria","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/7337/paroxysmal-nocturnal-hemoglobinuria","synonyms":["PNH","Marchiafava-Micheli disease"],"synonyms-with-source":[{"name":"PNH"},{"name":"Marchiafava-Micheli disease"}],"identifiers":[{"identifierType":"OMIM","identifierId":"300818"},{"identifierType":"OMIM","identifierId":"615399"},{"identifierType":"ORPHANET","identifierId":"447"},{"identifierType":"UMLS","identifierId":"C0024790"}]},"diseaseCategories":[{"diseaseTypeId":12,"diseaseTypeName":"Blood Diseases","source":"Orphanet"},{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"}],"organizations":[{"resourceID":636,"resourceName":"Aplastic Anemia and MDS International Foundation","abbreviation":"","address1":"4330 East-West Highway, Suite 230","address2":"","address3":"","address4":"","address5":"","city":"Bethesda","state":"MD","zip":"20814 ","country":"United States","phone":"+1-301-279-7202 ","tty":"","tollFree":"1-800-747-2820 Option 2 (Helpline)","fax":"+1-301-279-7205 ","email":"help@aamds.org","url":"https://www.aamds.org","freeText":""},{"resourceID":872,"resourceName":"European Network for Rare and Congenital Anaemias (ENERCA)","abbreviation":"","address1":"University of Barcelona","address2":"Red Cell Pathology Unit","address3":"C/Villarroel, 170 - 08036","address4":"Barcelona","address5":"","city":"","state":"","zip":"","country":"Espa√±a","phone":"(34) 93 451 5950","tty":"","tollFree":"","fax":"(34) 93 227 1764","email":"enerca@enerca.org","url":"http://www.enerca.org","freeText":""},{"resourceID":933,"resourceName":"American Autoimmune Related Diseases Association","abbreviation":"AARDA","address1":"19176 Hall Road, Suite 130","address2":"","address3":"","address4":"","address5":"","city":"Clinton Township","state":"MI","zip":"48038","country":"United States","phone":"586-776-3900","tty":"","tollFree":"800-598-4668","fax":"586-776-3903","email":"aarda@aarda.org","url":"https://www.aarda.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"Online Mendelian Inheritance in Man (OMIM) is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n<a href='http://www.omim.org/300818' target='_blank'>Paroxysmal nocturnal hemoglobinuria 1</a><br /><a href='http://www.omim.org/615399' target='_blank'>Paroxysmal nocturnal hemoglobinuria 2</a><br />","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/pubmed/?term=Paroxysmal+nocturnal+hemoglobinuria+%5Bti%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Paroxysmal nocturnal hemoglobinuria. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Paroxysmal+nocturnal+hemoglobinuria%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Paroxysmal nocturnal hemoglobinuria. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition=paroxysmalnocturnalhemoglobinuria' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Paroxysmal nocturnal hemoglobinuria. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/670/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/000534.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/207468-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=447' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1545,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The <a href='https://www.merckmanuals.com/professional/hematology-and-oncology/anemias-caused-by-hemolysis/paroxysmal-nocturnal-hemoglobinuria-pnh?query=paroxysmal%20nocturnal%20hemoglobinuria' target='_blank'>Merck Manuals Online Medical Library</a> provides information on this condition for patients and caregivers.&nbsp;","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1702,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='https://www.orpha.net/data/patho/Pro/en/Emergency_ParoxysmalNocturnalHaemoglobinuria.pdf' target='_blank'>Orphanet Emergency Guidelines</a> is an article which is expert-authored and peer-reviewed that is intended to guide health care professionals in emergency situations involving this condition. &nbsp;","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":1705,"resourceId":2846,"resourceName":"Project OrphanAnesthesia","descriptionText":"<a href='https://www.orphananesthesia.eu/en/rare-diseases/published-guidelines/paroxysmal-nocturnal-haemoglobinuria/222-paroxysmal-nocturnal-haemoglobinuria/file.html' target='_blank'>Project OrphanAnesthesia</a> is a project whose aim is to create peer-reviewed, readily accessible guidelines for patients with rare diseases and for the anesthesiologists caring for them. The project is a collaborative effort of the German Society of Anesthesiology and Intensive Care, Orphanet, the European Society of Pediatric Anesthesia, anesthetists and rare disease experts with the aim to contribute to patient safety.","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:0060284' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2158,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"<a href='https://rarediseases.org/for-patients-and-families/help-access-medications/patient-assistance-programs-2/' target='_blank'>National Organization for Rare Disorders</a> (NORD) has Disease-Specific Assistance Programs designed to help patients with out-of-pocket costs such as monthly insurance premiums or deductibles. In addition, some programs may provide financial assistance for additional expenses related to a patient's diagnosis such as travel to see a specialist.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"}],"overviewQuestion":{"questionId":3965,"questionText":"What is paroxysmal nocturnal hemoglobinuria?","answerText":"<strong>Paroxysmal nocturnal hemoglobinuria</strong> (PNH) is an acquired disorder that leads to the premature death and impaired production of blood cells. It can occur at any age, but is usually diagnosed in young adulthood. People with PNH have recurring episodes of symptoms due to <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002372.htm\" target=_blank>hemolysis</a>, which may be triggered by stresses on the body such as infections or physical exertion.&nbsp;This results in a deficiency of&nbsp;various types of blood cells and&nbsp;can cause signs and symptoms such as fatigue, weakness, abnormally pale skin (pallor), shortness of breath, and an increased heart rate. People with&nbsp;PNH may also be prone to infections&nbsp;and abnormal blood clotting (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/presentations/100168_1.htm\" target=_blank>thrombosis</a>) or hemorrhage, and are at increased risk of developing <a href=\"http://www.nlm.nih.gov/medlineplus/leukemia.html\" target=_blank>leukemia</a>. It is caused&nbsp;by <a href=\"http://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=46586\" target=_blank>acquired</a>, rather than inherited,&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=_blank>mutations</a> in the <em><a href=\"http://ghr.nlm.nih.gov/gene/PIGA\" target=_blank>PIGA</a></em> gene; the condition is not passed down to children of affected individuals.&nbsp;Sometimes, people who have been treated for <a href=\"http://www.nhlbi.nih.gov/health/dci/Diseases/aplastic/aplastic_whatis.html\" target=_blank>aplastic anemia</a> may develop PNH.[2896] The treatment of PNH is largely based on symptoms; <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003009.htm\" target=_blank>stem cell transplantation</a> is typically reserved for severe cases of PNH with aplastic anemia or those whose develop leukemia.[2897]","dateModified":"2011-01-15T15:11:00"},"basicQuestions":[],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":29133,"abbreviatedInquiry":"Why does it appear that&nbsp;hemolysis occurs mostly&nbsp;at night?","caseQuestions":[{"questionId":3966,"questionText":"Why does it appear that hemolysis mostly occurs at night?","answerText":"The term \"nocturnal\" refers to the belief that <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002372.htm\" target=_blank>hemolysis</a> is triggered by <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000092.htm\" target=_blank>acidosis</a> during sleep. However, this observation was later disproved. In individuals with paroxysmal nocturnal hemoglobinuria, hemolysis has been shown to occur throughout the day, but the urine concentrated overnight produces the dramatic change in color.[2897] It is most noticeable in the morning, upon passing urine that has accumulated in the bladder during the night.[2896]","dateModified":"2011-01-15T15:06:00","references":[{"referenceId":2896,"authors":"","articleTitle":"Paroxysmal nocturnal hemoglobinuria","bookWebsiteJournalTitle":"Genetics Home Reference","date":"May 2007","url":"http://ghr.nlm.nih.gov/condition/paroxysmal-nocturnal-hemoglobinuria","dateAccessed":"2011-01-15T00:00:00"},{"referenceId":2897,"authors":"Emmanuel C Besa and Ulrich Woermann","articleTitle":"Paroxysmal Nocturnal Hemoglobinuria","bookWebsiteJournalTitle":"eMedicine","date":"March 27, 2009","url":"http://emedicine.medscape.com/article/207468-overview","dateAccessed":"2011-01-15T00:00:00"}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":13704,"phenoTypeName":"Fatigue","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15517,"phenoTypeName":"Hemolytic anemia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9566,"phenoTypeName":"Bone marrow hypocellularity","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11808,"phenoTypeName":"Hypercoagulability","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":15543,"phenoTypeName":"Thromboembolism","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13419,"phenoTypeName":"Abdominal pain","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15531,"phenoTypeName":"Abnormal bleeding","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":455,"phenoTypeName":"Abnormal renal physiology","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9006,"phenoTypeName":"Angina pectoris","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15549,"phenoTypeName":"Aplastic anemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15172,"phenoTypeName":"Cerebral artery stenosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13402,"phenoTypeName":"Dysphagia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":12800,"phenoTypeName":"Hemoglobinuria","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15544,"phenoTypeName":"Hypoplastic anemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9419,"phenoTypeName":"Muscle weakness","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":7953,"phenoTypeName":"Myelodysplasia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8988,"phenoTypeName":"Myocardial infarction","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8266,"phenoTypeName":"Pallor","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13730,"phenoTypeName":"Pulmonary arterial hypertension","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8074,"phenoTypeName":"Pulmonary embolism","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11415,"phenoTypeName":"Transient ischemic attack","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9970,"phenoTypeName":"Acute myeloid leukemia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":7919,"phenoTypeName":"Arthralgia","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":13401,"phenoTypeName":"Diarrhea","percentRanges":"-"},{"phenoTypeId":13726,"phenoTypeName":"Dyspnea","percentRanges":"-"},{"phenoTypeId":11409,"phenoTypeName":"Headache","percentRanges":"-"},{"phenoTypeId":9978,"phenoTypeName":"Paroxysmal nocturnal hemoglobinuria","percentRanges":"-"},{"phenoTypeId":8123,"phenoTypeName":"Somatic mutation","percentRanges":"-"},{"phenoTypeId":8303,"phenoTypeName":"Urticaria","percentRanges":"-"}],"medicalProducts":[{"productId":10,"genericName":"Eculizumab","tradeName":"Soliris","tradeLink":"https://soliris.net/home/","manufacturer":"","sponsor":"Alexion Pharmaceuticals, Inc.","indication":"March 2007, eculizumab (Soliris) was approved for the treatment of paroxysmal nocturnal hemoglobinuria to reduce hemolysis.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/soliris","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a612024.html"},{"productId":751,"genericName":"Ravulizumab-cwvz","tradeName":"Ultomiris","tradeLink":"https://www.ultomiris.com/","manufacturer":"","sponsor":"Alexion Pharmaceuticals, Inc.","indication":"December 2018, ravulizumab-cwvz (Ultomiris) was approved for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH).","drugInformationLink":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a9a590d9-0217-43c7-908d-e62a71279791","medlinePlusLink":""}],"EncodedName":"Paroxysmal_nocturnal_hemoglobinuria"}